4/A//SEC Filing
Segal Lloyd Mitchell 4/A
Accession 0001209191-22-004623
CIK 0001808158other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:55 PM ET
Size
5.9 KB
Accession
0001209191-22-004623
Insider Transaction Report
Form 4/AAmended
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-01-21+300,000→ 300,000 totalExercise: $15.63Exp: 2032-01-20→ Common Shares (300,000 underlying)
Footnotes (2)
- [F1]This Form 4 amendment is being filed to correct the original Form 4 filed on January 20, 2022. The original Form 4 was filed early with an incorrect Transaction Date due to a clerical error.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001477123
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:55 PM ET
- Size
- 5.9 KB